AstraZeneca COVID-19 vaccine on track for 2020 filing: Soriot

AstraZeneca COVID-19 vaccine on track for 2020 filing: Soriot

Soriot said that the decision to resume the coronavirus vaccine trials rests with a group of independent experts who are working to understand if the volunteer's condition was coincidental or a result of the vaccine.

Soriot said during a call that it was very common for a trial to be suspended, the difference being that the world was now watching. He said, though, that he still expects a set of data from the trials that can be presented to regulators for approval by the end of the year.

The guidelines were issued the same day President Donald Trump told the Republican National Convention that a vaccine may be available before the end of the year, the Times reported. AstraZeneca has signed deals with several governments, manufacturers and other institutions around the world to help it make and distribute its vaccine world-wide.

India Registers Highest Overnight Surge In COVID-19 Cases, Fatalities
India on Friday recorded an unprecedented rise in single-day spike both in number of fresh cases and deaths in 24 hours. They account for over more than 60 per cent of the active cases, according to the Ministry.

Why It Matters: According to the WHO, there are more than 169 COVID-19 vaccine candidates in development across the world, 26 of which are now undergoing clinical trials.

The University of Hong Kong (HKU) announced on Wednesday that its nasal spray vaccine for coronavirus has secured regulatory approval for clinical trials on humans, per the local news agency ECNS report.

The patient was reportedly suffering from neurological symptoms associated with a rare spinal inflammatory disorder called transverse myelitis. But she says trials must be conducted in tens of thousands of people to determine whether a vaccine can safely protect people from infection. AstraZeneca also had been testing the vaccine in countries including South Africa and Brazil.

Related Articles